These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18846911)

  • 21. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
    Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
    Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case files from Stanford University Medical Center: ten years of HAART: a long wait for full HIV suppression.
    Shulman N; Shafer RW
    MedGenMed; 2007 Jan; 9(1):10. PubMed ID: 17435619
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiretroviral therapy adherence in children: outcomes from Africa.
    Reddi A; Leeper SC
    AIDS; 2008 Apr; 22(7):906-7. PubMed ID: 18427213
    [No Abstract]   [Full Text] [Related]  

  • 24. Alterations in acute-phase proteins among HIV-1 infected persons receiving generic HAART in southern India.
    Sundaram M; Srinivas CN; Shankar EM; Balakrishnan P; Solomon S; Kumarasamy N
    J Infect; 2009 Jun; 58(6):465-7. PubMed ID: 19443037
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV-associated multicentric Castleman's disease.
    Stebbing J; Pantanowitz L; Dayyani F; Sullivan RJ; Bower M; Dezube BJ
    Am J Hematol; 2008 Jun; 83(6):498-503. PubMed ID: 18260115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HIV Infection in the elderly].
    Brañas F; Serra JA
    Rev Esp Geriatr Gerontol; 2009; 44(3):149-54. PubMed ID: 19443084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
    Shah SU; Kerkar SP; Pazare AR
    Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting.
    Sungkanuparph S; Wongprasit P; Manosuthi W; Atamasirikul K
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):863-6. PubMed ID: 19058581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endobronchial extension of granulomatous lymphadenitis in an HIV-positive man with immune reconstitution syndrome.
    Steinfort DP; Smallwood D; Antippa P; Irving LB
    Respirology; 2009 Sep; 14(7):1064-6. PubMed ID: 19740269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Can antiretroviral treatment eradicate Prurigo nodularis in HIV infected patients?].
    Ouattara I; Eholié SP; Aoussi E; Bissagnéne E; Raffi F
    Med Mal Infect; 2009 Jun; 39(6):415-6. PubMed ID: 19423251
    [No Abstract]   [Full Text] [Related]  

  • 32. Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.
    Gómez-Puerta JA; Espinosa G; Miró JM; Sued O; Llibre JM; Cervera R; Font J
    Isr Med Assoc J; 2006 Jul; 8(7):513-4. PubMed ID: 16889175
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of antiretroviral agents in cirrhotic patients infected by HIV].
    Salmon-Céron D
    Med Mal Infect; 2004 Nov; 34 Spec No 2():14-9. PubMed ID: 15801534
    [No Abstract]   [Full Text] [Related]  

  • 34. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools?
    Friis-Møller N; Worm SW
    Clin Infect Dis; 2007 Oct; 45(8):1082-4. PubMed ID: 17879929
    [No Abstract]   [Full Text] [Related]  

  • 36. Routine childhood bacille Calmette Guérin immunization and HIV infection.
    von Reyn CF
    Clin Infect Dis; 2006 Feb; 42(4):559-61. PubMed ID: 16421801
    [No Abstract]   [Full Text] [Related]  

  • 37. Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass.
    Manfredi R; Sabbatani S; Chiodo F
    Scand J Infect Dis; 2005; 37(10):781-3. PubMed ID: 16191903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series.
    Bestawros A; Michel R; Séguin C; Routy JP
    Am J Hematol; 2008 Jun; 83(6):508-11. PubMed ID: 18027834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis virus coinfection in the Strategic Management of Antiretroviral Therapy (SMART) study: a marker for nonliver, non-opportunistic disease mortality.
    Wyles DL
    Clin Infect Dis; 2008 Dec; 47(11):1476-8. PubMed ID: 18959495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.